stocks logo

DXR Valuation

Daxor Corp
$
7.680
+0.022(+0.290%)
  • Overview
  • Forecast
  • Valuation

DXR Relative Valuation

DXR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DXR is overvalued; if below, it's undervalued.

Historical Valuation

No Data

Competitors Valuation Multiple

The average P/S ratio for DXR's competitors is 92.16, providing a benchmark for relative valuation. Daxor Corp Corp (DXR) exhibits a P/S ratio of 367.38, which is 298.64% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

FAQ

arrow icon

Is Daxor Corp (DXR) currently overvalued or undervalued?

Daxor Corp (DXR) is now in the Fair zone, suggesting that its current forward PE ratio of 1.53 is considered Fairly compared with the five-year average of 188.59. The fair price of Daxor Corp (DXR) is between 6.71 to 7.78 according to relative valuation methord.
arrow icon

What is Daxor Corp (DXR) fair value?

arrow icon

How does DXR's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for Daxor Corp (DXR) as of May 20 2025?

arrow icon

What is the current FCF Yield for Daxor Corp (DXR) as of May 20 2025?

arrow icon

What is the current Forward P/E ratio for Daxor Corp (DXR) as of May 20 2025?

arrow icon

What is the current Forward P/S ratio for Daxor Corp (DXR) as of May 20 2025?